[Retracted] Novel lncRNA AL033381.2 Promotes Hepatocellular Carcinoma Progression by Upregulating PRKRA Expression

Feiran Wang, Lirong Zhu, Qiang Xue, Chong Tang, Weidong Tang, Nannan Zhang, Chen Dai, Zhong Chen

Open source

DOI
10.1155/2022/1125932
Published
2022-01
Container
Oxidative Medicine and Cellular Longevity
Publisher
Wiley
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2022/1125932,
  title = {[Retracted] Novel lncRNA AL033381.2 Promotes Hepatocellular Carcinoma Progression by Upregulating PRKRA Expression},
  author = {Feiran Wang and Lirong Zhu and Qiang Xue and Chong Tang and Weidong Tang and Nannan Zhang and Chen Dai and Zhong Chen},
  year = {2022},
  journal = {Oxidative Medicine and Cellular Longevity},
  doi = {10.1155/2022/1125932},
  url = {https://doi.org/10.1155/2022/1125932}
}

RIS

TY  - JOUR
TI  - [Retracted] Novel lncRNA AL033381.2 Promotes Hepatocellular Carcinoma Progression by Upregulating PRKRA Expression
AU  - Feiran Wang
AU  - Lirong Zhu
AU  - Qiang Xue
AU  - Chong Tang
AU  - Weidong Tang
AU  - Nannan Zhang
AU  - Chen Dai
AU  - Zhong Chen
PY  - 2022
JO  - Oxidative Medicine and Cellular Longevity
DO  - 10.1155/2022/1125932
UR  - https://doi.org/10.1155/2022/1125932
ER  - 

APA

Wang, F., Zhu, L., Xue, Q., Tang, C., Tang, W., Zhang, N., Dai, C., & Chen, Z. (2022). [Retracted] Novel lncRNA AL033381.2 Promotes Hepatocellular Carcinoma Progression by Upregulating PRKRA Expression. Oxidative Medicine and Cellular Longevity. https://doi.org/10.1155/2022/1125932

Source records